|
24 |
2022 IVRA International Medical Conference held successfully
2024-03-14
31
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-14 |
31 |
|
23 |
‘K-Medical Device’ winning 1st place in Malaysian Oncology Society paper
2024-03-29
30
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-29 |
30 |
|
22 |
World's first joint collaboration to overcome COVID-19 treatment, IVRA is launched.
2024-03-12
29
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
29 |
|
21 |
“Angola, no exception to the COVID-19 threat, recognizes the value of REMISSION 1℃”
2024-03-12
28
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
28 |
|
20 |
AdipoLABs signs research MOU with University of Cyber Jaya, Malaysia
2024-03-28
28
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-28 |
28 |
|
19 |
AdipoLABs’ ‘REMISSION 1℃’ cancer treatment effect recognized internationally
2024-03-29
27
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-29 |
27 |
|
17 |
AdipoLABs signs research MOU with University of Cyber Jaya, Malaysia
2024-03-28
26
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-28 |
26 |
|
16 |
AdipoLABs CEO Han Sung-ho visits the National Cemetery
2024-03-12
25
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
25 |
|
15 |
Presentng a new direction for COVID-19 and cancer treatment
2024-03-12
25
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
25 |
|
14 |
AdipoLABs launches ‘high-frequency hyperthermia cancer treatment device’ in Malaysia
2024-03-29
25
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-29 |
25 |
|
13 |
“COVID-19 treatment needs a major shift to hyperthermia therapy.”
2024-03-12
23
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
23 |
|
12 |
‘REMISSION 1℃’ expected to be a ‘game changer’ in COVID-19 treatment
2024-03-12
22
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
22 |
